MAHMVGADDIESLRVELAEIGRSIRSSFRRHTSSFRSSSSIYEVENDGDVNDHDAEYALQWAEIERLPTVKRMRSTLLDDGDESMTEKGRRVVDVTKLGAVERHLMIEKLIKHIENDNLKLLKKIRRRIDRVGMELPTIEVRYESLKVVAECEVVEGKALPTLWNTAKRVLSELVKLTGAKTHEAKINIINDVNGIIKPGRLTLLLGPPSCGKTTLLKALSGNLENNLKCSGEISYNGHRLDEFVPQKTSAYISQYDLHIAEMTVRETVDFSARCQGVGSRTDIMMEVSKREKEKGIIPDTEVDAYMKAISVEGLQRSLQTDYILKILGLDICAEILIGDVMRRGISGGQKKRLTTAEMIVGPTKALFMDEITNGLDSSTAFQIVKSLQQFAHISSATVLVSLLQPAPESYDLFDDIMLMAKGRIVYHGPRGEVLNFFEDCGFRCPERKGVADFLQEVISKKDQAQYWWHEDLPYSFVSVEMLSKKFKDLSIGKKIEDTLSKPYDRSKSHKDALSFSVYSLPNWELFIACISREYLLMKRNYFVYIFKTAQLVMAAFITMTVFIRTRMGIDIIHGNSYMSALFFALIILLVDGFPELSMTAQRLAVFYKQKQLCFYPAWAYAIPATVLKVPLSFFESLVWTCLSYYVIGYTPEASRFFKQFILLFAVHFTSISMFRCLAAIFQTVVASITAGSFGILFTFVFAGFVIPPPSMPAWLKWGFWANPLSYGEIGLSVNEFLAPRWNQMQPNNFTLGRTILQTRGMDYNGYMYWVSLCALLGFTVLFNIIFTLALTFLKSPTSSRAMISQDKLSELQGTEKSTEDSSVRKKTTDSPVKTEEEDKMVLPFKPLTVTFQDLNYFVDMPVEMRDQGYDQKKLQLLSDITGAFRPGILTALMGVSGAGKTTLLDVLAGRKTSGYIEGDIRISGFPKVQETFARVSGYCEQTDIHSPNITVEESVIYSAWLRLAPEIDATTKTKFVKQVLETIELDEIKDSLVGVTGVSGLSTEQRKRLTIAVELVANPSIIFMDEPTTGLDARAAAIVMRAVKNVADTGRTIVCTIHQPSIDIFEAFDELVLLKRGGRMIYTGPLGQHSRHIIEYFESVPEIPKIKDNHNPATWMLDVSSQSVEIELGVDFAKIYHDSALYKRNSELVKQLSQPDSGSSDIQFKRTFAQSWWGQFKSILWKMNLSYWRSPSYNLMRMMHTLVSSLIFGALFWKQGQNLDTQQSMFTVFGAIYGLVLFLGINNCASALQYFETERNVMYRERFAGMYSATAYALGQVVTEIPYIFIQAAEFVIVTYPMIGFYPSAYKVFWSLYSMFCSLLTFNYLAMFLVSITPNFMVAAILQSLFYVGFNLFSGFLIPQTQVPGWWIWLYYLTPTSWTLNGFISSQYGDIHEEINVFGQSTTVARFLKDYFGFHHDLLAVTAVVQIAFPIALASMFAFFVGKLNFQRR

peptide	modifiedsequence	code	pepprot	motif_name
TTDSPVKTEEEDK	TTD(pS)PVKTEEEDK	AT3G53480.1	S831	unknownmotif:D-S; unknownmotif:S-P; MAPK/CDC2:S-P; CDK1:[ST]-P-X-[KR]

AT3G53480.1

Description:

pleiotropic drug resistance 9

Solute transport.primary active transport.ABC superfamily.ABC2 family.subfamily ABCG transporter

ABCtransporter-like,ATP-bindingdomain PF00005;ABC-2typetransporter PF01061;PlantPDRABCtransporterassociated PF08370;ABC-transporter,N-terminaldomain PF14510;ABCtransporterfamilyGdomain PF19055;